BOSTON, Jan. 27 /PRNewswire-FirstCall/ -- ViaCell, Inc. (Nasdaq: VIAC - News) announced the completion of its initial public offering of 7,500,000 shares of common stock. In addition, the underwriters of its initial public offering exercised their over-allotment option in full and purchased an additional 1,125,000 shares of common stock. All such shares were sold by ViaCell at the initial public offering price of $7 per share, less underwriting discounts and commissions. //// Stem Cell related Bio's (rev)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.